Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG37682

H2AC14 Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

The H2AC14 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population with disrupted H2AC14, a core histone H2A critical for nucleosome assembly and chromatin organization. This loss-of-function model depletes H2AC14, altering interactions with histone chaperones like NAP1L1 and the FACT complex, and perturbing downstream chromatin structure and gene regulation under control of NPAT/Cyclin E/CDK2 signaling. Applications include nucleosome occupancy mapping (MNase-seq), chromatin fractionation, cell cycle profiling, co-immunoprecipitation of histone complexes, and western blotting. It is suitable for studying histone dosage effects, synthetic lethal interactions, epigenetic drug responses, and DNA damage repair pathways in cervical adenocarcinoma research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    H2AC14

    Gene Identifier

    NCBI Gene ID 8331

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The H2AC14 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population derived from HeLa cells, with disruption of the H2AC14 gene encoding a core histone H2A. This heterogeneous pool contains diverse editing events at the target locus, resulting in loss of H2AC14 protein. The polyclonal format minimizes clonal selection bias and faithfully represents the spectrum of knockout phenotypes across the cell population, making it suitable for studies of histone depletion effects on chromatin.

HeLa cells are an immortalized, HPV18-positive epithelial cell line derived from a cervical adenocarcinoma, characterized by aneuploidy and active telomerase. They serve as a standard model for human epithelial cell biology, cancer mechanisms, and pharmacological studies. The extensive use of HeLa cells in chromatin research and the availability of established protocols make them an ideal host for generating H2AC14 knockout cells, facilitating investigation of nucleosome structure and function in a cancer-relevant background.

H2AC14 is a canonical core histone essential for nucleosome assembly and chromatin organization. It interacts with histones H2B, H3, H4, and chaperones including NAP1L1, the FACT complex (SUPT16H, SSRP1), and CAF-1 (CHAF1A, CHAF1B, RBBP4). H2AC14 expression is controlled by the NPAT/HiNF-P complex downstream of Cyclin E/CDK2 and E2F transcription factors, coupling histone production to DNA replication. Knockout of H2AC14 disrupts nucleosome integrity, alters chromatin architecture, and impairs interactions with modifiers such as EZH2 and HDACs, leading to altered gene expression and compromised DNA damage responses.

In HeLa cells, H2AC14 depletion models histone insufficiency resembling chromatin dysregulation in cancer. Loss of this core histone reduces nucleosome occupancy, promoting genomic instability and aberrant transcription. This system is particularly useful for studying oncogenic mechanisms driven by altered histone stoichiometry, as seen in cervical and other malignancies. The polyclonal population captures a range of knockout effects, enabling robust analysis of cell cycle defects, replication stress, and sensitivity to genotoxic agents without clonal adaptation artifacts.

Applications include analyzing histone dosage effects on chromatin dynamics, nucleosome assembly, and genome stability using techniques such as MNase-seq, chromatin fractionation, and RNA-seq. The knockout cells are also suited for cell cycle profiling by flow cytometry, western blotting of histone complexes, co-immunoprecipitation of interaction partners, Comet assays for DNA damage, and proliferation assays to screen synthetic lethal interactions or epigenetic drug responses. For further information, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)